QTX125
/ Quimatryx, HiDiamond Biotechnology
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 29, 2023
Multifunctional CaCO@Cur@QTX125@HA nanoparticles for effectively inhibiting growth of colorectal cancer cells.
(PubMed, J Nanobiotechnology)
- "Encouragingly, CaCO@Cur@QTX125@HA nanoparticles successfully internalized into CRC patient-derived organoid (PDO) models and induced apoptosis of tumor cells. The multifunctional CaCO@Cur@QTX125@HA nanoparticles hold promise for the treatment of CRC."
Journal • CNS Disorders • Colorectal Cancer • Gastrointestinal Cancer • Oncology • Psychiatry • Solid Tumor
1 to 1
Of
1
Go to page
1